16-29664354-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003123.6(SPN):c.626C>T(p.Thr209Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,613,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003123.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPN | NM_003123.6 | c.626C>T | p.Thr209Ile | missense_variant | 2/2 | ENST00000652691.1 | |
SPN | NM_001030288.4 | c.626C>T | p.Thr209Ile | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPN | ENST00000652691.1 | c.626C>T | p.Thr209Ile | missense_variant | 2/2 | NM_003123.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152050Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251276Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135838
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461402Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727042
GnomAD4 genome AF: 0.000243 AC: 37AN: 152168Hom.: 0 Cov.: 31 AF XY: 0.000242 AC XY: 18AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.626C>T (p.T209I) alteration is located in exon 2 (coding exon 1) of the SPN gene. This alteration results from a C to T substitution at nucleotide position 626, causing the threonine (T) at amino acid position 209 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at